Latest Share Chat

REMOVE ADS

Scancell Holdings Share News (SCLP)

Scancell Holdings Information

Share Price Information for Scancell Holdings (SCLP)

Share Price is delayed by 15 minutes

Get Live Data

22.50 0.10 (0.44%)

Bid:

22.00

Ask:

23.00

Spread: 1.00 (4.545%)

Market Cap: £234.54m

Last checked at -

Intraday Scancell Holdings Share Chart

REMOVE ADS

Scancell Holdings News

Scancell Rises As It Gets More Good Results From Skin Cancer Treatment Trial

LONDON (Alliance News) - Cancer treatment developer Scancell Holdings PLC saw its shares rise Monday after it said the latest results from a trial of ...

Oxford Technology NAV Declines, Appealing VCT Status Withdrawal

LONDON (Alliance News) - Oxford Technology VCT PLC saw its net asset value per share decline in the year to end-February, and said it was appealing th...

Scancell Holdings To Present Phase I/II ImmunoBody Trial Data At ASCO

LONDON (Alliance News) - Scancell Holdings PLC said Thursday that it will announce the latest data from its ongoing Phase I/II clinical trial of its S...

UK MIDDAY BRIEFING: Lloyds Kicks Off Bank Season With Improvement

LONDON (Alliance News) - Lloyds Banking Group kicked off the first-quarter bank earnings season Thursday, reporting that its pretax profit dropped by ...

UK WINNERS & LOSERS: Lloyds Atop FTSE 100 Risers; Weir Leads Fallers

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.-------FTSE 100 - WINN...

Scancell Rises As Long-Time Consultant Joins Its Board

LONDON (Alliance News) - Cancer treatment developer Scancell Holdings PLC saw its shares rise Thursday after it appointed long-time consultant Dr Sall...

Scancell To Announce Phase I/II Of Melanoma Clinical Trial On April 8

LONDON (Alliance News) - Scancell Holdings PLC Friday said that it will announce the results of phase one and two of its clinical trial in patients wi...

Scancell Holdings Completes Phase 1 Of Melanoma Clinical Trial

LONDON (Alliance News) - Scancell Holdings PLC Friday said it has completed patient dosing with 8mg of SCIB1 ImmunoBody in part one of its on-going ph...